HR
Homi Rustam Khusrokhan
About Homi Rustam Khusrokhan
Data last updated:
Homi Rustam Khusrokhan is a Director at Strides Pharma Science Limited (since 2017), Director at Neuland Laboratories Ltd (since 2019) and Director at The Anglo Scottish Education Society (since 1995). The companies operate in Pharma, Education and Engineering. The 3 current companies with reported revenue have a combined latest revenue of ₹6,571 Cr; the largest is Strides Pharma Science Limited at ₹5,009 Cr (FY 2026). Earlier, Homi Rustam Khusrokhan was a Director at Samson Maritime Limited (2009–2024) and Director at Rallis India Limited (2003–2013) and 10 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Strides Pharma Science Limited L24230MH1990PLC057062 | Director | 18 May 2017 | 1990 | ₹5,009 Cr (FY 2026) | Active |
 Neuland Laboratories Ltd L85195TG1984PLC004393 | Director | 12 Feb 2019 | 1984 | ₹1,497 Cr (FY 2025) | Active |
 The Anglo Scottish Education Society U83000MH1926NPL001231 | Director | 26 Sep 1995 | 1926 | ₹63.94 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Samson Maritime Limited U35112MH1994PLC081331 | Director | 29 Apr 2009 | 1994 | ₹197 Cr (FY 2025) | Active |
 Rallis India Limited L36992MH1948PLC014083 | Director | 24 Mar 2003 | 1948 | ₹2,939 Cr (FY 2026) | Active |
 Lic Mutual Fund Trustee Private Limited U65992MH2003PTC139955 | Director | 18 Jan 2011 | 2003 | ₹53.3 Lakh (FY 2025) | Active |
 Tata Chemicals Limited L24239MH1939PLC002893 | Managing Director | 16 Oct 2006 | 1939 | ₹14,900 Cr (FY 2026) | Active |
 Amanta Healthcare Limited L24139GJ1994PLC023944 | Director | 14 Dec 2012 | 1994 | ₹276 Cr (FY 2025) | Active |
 Tata Aia Life Insurance Company Limited U66010MH2000PLC128403 | Director | 14 Oct 2009 | 2000 | Active | |
 Novalead Pharma Private Limited U73100PN2007PTC130929 | Director | 24 Dec 2009 | 2007 | ₹16.4 Lakh (FY 2024) | Active |
 Centre For Advancement Of Philanthropy U73200MH1986NPL041521 | Director | 15 Apr 2011 | 1986 | ₹91.7 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Homi Rustam Khusrokhan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Homi Rustam Khusrokhan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Homi Rustam Khusrokhan
Homi Rustam Khusrokhan currently holds 3 directorships: Strides Pharma Science Limited (Director, since 18 May 2017, revenue ₹5,009 Cr (FY 2026)); Neuland Laboratories Ltd (Director, since 12 Feb 2019, revenue ₹1,497 Cr (FY 2025)); The Anglo Scottish Education Society (Director, since 26 Sep 1995, revenue ₹63.94 Cr (FY 2023)).
Homi Rustam Khusrokhan was first appointed on 26 Sep 1995 as Director at The Anglo Scottish Education Society. The most recent appointment on record is 12 Feb 2019 at Neuland Laboratories Ltd.
The 3 current companies of Homi Rustam Khusrokhan that report revenue have a combined latest revenue of ₹6,571 Cr: Strides Pharma Science Limited ₹5,009 Cr (FY 2026); Neuland Laboratories Ltd ₹1,497 Cr (FY 2025); The Anglo Scottish Education Society ₹63.94 Cr (FY 2023).
Homi Rustam Khusrokhan held 12 earlier board appointments: Samson Maritime Limited (Director, 29 Apr 2009 to 31 Mar 2024); Rallis India Limited (Director, 24 Mar 2003 to 31 Dec 2013); Lic Mutual Fund Trustee Private Limited (Director, 18 Jan 2011 to 31 Mar 2015); Tata Chemicals Limited (Managing Director, 16 Oct 2006 to 14 Dec 2008); Amanta Healthcare Limited (Director, 14 Dec 2012 to 07 Dec 2017); and 7 more.
The current boards of Homi Rustam Khusrokhan's companies include Aditya Arun Kumar (Strides Pharma Science Limited), Ameet Pratapsinh Hariani (Strides Pharma Science Limited), Arun Kumar Pillai (Strides Pharma Science Limited), Badree Komandur (Strides Pharma Science Limited), Badree Komandur (Strides Pharma Science Limited), Kausalya Santhanam (Strides Pharma Science Limited), among others.